Testicular cancer and heredity
Project
|Last update
Testicular cancer is the most frequent form of cancer among young men, and much indicates that the foundation for the disease is laid already in fetal life. In this Norwegian-Swedish collaborative project, genes that may be important for the development of testicular cancer will be investigated.
Background
Testicular cancer is the most frequent form of cancer among young men, and in Norway around 270 men are affected annually by this type of cancer. It is still unknown why testicular cancer occurs, but there is consensus that both genetic and environmental factors play a role. There are strong indications that the foundations of the disease are laid already in fetal life. Brothers, sons and fathers of patients with testicular cancer are at increased risk for the disease. With the help of surgery, chemotherapy and radiation therapy, more than 95 percent of patients are cured.
The last 50 years have seen a sharp increase in the incidence of testicular cancer, and the incidence in Norway is one of the highest in the world. By comparison, Sweden has around half as much incidence of testicular cancer as Norway. The reason for this is unknown.
Purpose
The project is a collaboration between Norway (Cancer Registry of Norway and Oslo University College) and Sweden (Karolinska Institutet). We are particularly interested in investigating whether gene variants that regulate exposure to sex hormones in the womb affect the risk of this type of cancer.
In this connection, saliva samples will be collected from men who were diagnosed with testicular cancer in the period 1990-2006, and who were aged 18-45 years when they were diagnosed. The persons concerned will be contacted by letter and asked to participate in the project. Participation involves them providing a saliva sample. The parents will also receive a request to provide a saliva sample, but only after their son has given permission for them to be contacted.
The unique feature of this project is the collection of saliva samples – not only from former patients – but also from their parents. The samples will be used for genetic analyses. We imagine that genetic variations may have an impact on the risk of developing testicular cancer. Since testicular cancer most likely occurs already in fetal life, genetic variations in the mother may also be important.
The academic communities involved have extensive experience and expertise in testicular cancer research. The project is expected to provide valuable knowledge about the interaction between genes and the environment in foetal life with regard to the risk of developing testicular cancer. Furthermore, the study can contribute to a better understanding of the large difference in prevalence between Norway and Sweden. In the long term, the results can hopefully also help reduce the incidence of this type of cancer.
About the project
Project leader: Marcin Wojewodzic
Financing: The Project is financed with funds from the Norwegian Cancer Society and the Nordic Cancer Union (NCU).